luismmolina/iStock via Getty Images Adaptimmune Therapeutics (NASDAQ:ADAP) was a big winner a couple of years ago following impressive data from the company’s Phase I ADP-A2M4 “afami-cel” trial. The ticker jumped from around $1 per share […]
Johnny Greig/DigitalVision via Getty Images Summit Materials (NYSE:SUM), a leading North American materials-based company, looks to have already made meaningful progress just a year into its medium-term strategy, allowing for a more aggressive capital allocation […]
funky-data/iStock Unreleased via Getty Images Dropbox (NASDAQ:DBX) IPO’ed in March 2018, going public at $21 per share and opening at $29. It currently trades for ~$20.65 four years later, despite massive improvements to its financials. […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.